Alternative Venous Pathways: A Potential Key Imaging Feature for Early Diagnosis of Sturge-Weber Syndrome Type 1

References

1. 1.↵
   1. Vellieux G,
   2. Frazzini V,
   3. Pichit P, et al

   . A review of the natural history of Sturge-Weber syndrome through adulthood. J Neurol 2022;269:4872–83 doi:10.1007/s00415-022-11132-9 pmid:35508811

   CrossRefPubMed
2. 2.↵
   1. Juhász C,
   2. Haacke EM,
   3. Hu J, et al

   . Multimodality imaging of cortical and white matter abnormalities in Sturge-Weber syndrome. AJNR Am J Neuroradiol 2007;28:900–06 pmid:17494666

   Abstract/FREE Full Text
3. 3.↵
   1. Sarma A,
   2. Martin D,
   3. Pruthi S, et al

   . Imaging the cerebral veins in pediatric patients: beyond dural venous sinus thrombosis. Radiographics 2023;43:e220129 doi:10.1148/rg.220129 pmid:36656758

   CrossRefPubMed
4. 4.↵
   1. Clifford SM,
   2. Ghosh A,
   3. Zandifar A, et al

   . Arterial spin-labeled (ASL) perfusion in children with Sturge-Weber syndrome: a retrospective cross-sectional study. Neuroradiology 2023;65:1825–34 doi:10.1007/s00234-023-03224-8 pmid:37794141

   CrossRefPubMed
5. 5.↵
   1. Comi AM

   . Sturge-Weber syndrome. Handb Clin Neurol 2015;132:157–68 doi:10.1016/B978-0-444-62702-5.00011-1 pmid:26564078

   CrossRefPubMed
6. 6.↵
   1. Vedmurthy P,
   2. Pinto ALR,
   3. Lin DDM, et al

   ; BCH-KKI SWS Pre-symptomatic Biomarker Working Group. Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber. BMJ Open 2022;12:e053103 doi:10.1136/bmjopen-2021-053103 pmid:35121603

   Abstract/FREE Full Text
7. 7.↵
   1. Sudarsanam A,
   2. Ardern-Holmes SL

   . Sturge-Weber syndrome: from the past to the present. Eur J Paediatr Neurol 2014;18:257–66 doi:10.1016/j.ejpn.2013.10.003 pmid:24275166

   CrossRefPubMed
8. 8.↵
   1. Miao Y,
   2. Juhász C,
   3. Wu J, et al

   . Clinical correlates of white matter blood flow perfusion changes in Sturge-Weber syndrome: a dynamic MR perfusion-weighted imaging study. AJNR Am J Neuroradiol 2011;32:1280–85 doi:10.3174/ajnr.A2540 pmid:21724573

   Abstract/FREE Full Text
9. 9.↵
   1. Lin DDM,
   2. Barker PB,
   3. Kraut MA, et al

   . Early characteristics of Sturge-Weber syndrome shown by perfusion MR imaging and proton MR spectroscopic imaging. AJNR Am J Neuroradiol 2003;24:1912–15 pmid:14561628

   PubMedWeb of Science
10. 10.↵
    1. Pouliquen G,
    2. Fillon L,
    3. Dangouloff-Ros V, et al

    . Arterial spin-labeling perfusion imaging in the early stage of Sturge-Weber syndrome. AJNR Am J Neuroradiol 2022;43:1516–22 doi:10.3174/ajnr.A7643 pmid:36137664

    Abstract/FREE Full Text
11. 11.↵
    1. Zallmann M,
    2. Mackay MT,
    3. Leventer RJ, et al

    . Retrospective review of screening for Sturge-Weber syndrome with brain magnetic resonance imaging and electroencephalography in infants with high-risk port-wine stains. Pediatr Dermatol 2018;35:575–81 doi:10.1111/pde.13598 pmid:30020536

    CrossRefPubMed
12. 12.↵
    1. Bar C,
    2. Pedespan J-M,
    3. Boccara O, et al

    . Early magnetic resonance imaging to detect presymptomatic leptomeningeal angioma in children with suspected Sturge-Weber syndrome. Dev Med Child Neurol 2020;62:227–33 doi:10.1111/dmcn.14253 pmid:31050360

    CrossRefPubMed
13. 13.↵
    1. Pearl M,
    2. Gregg L,
    3. Gandhi D

    . Cerebral venous development in relation to developmental venous anomalies and vein of Galen aneurysmal malformations. Semin Ultrasound CT MR 2011;32:252–63 doi:10.1053/j.sult.2011.02.001 pmid:21596280

    CrossRefPubMed
14. 14.↵
    1. Raybaud C

    . Normal and abnormal embryology and development of the intracranial vascular system. Neurosurg Clin N Am 2010;21:399–426 doi:10.1016/j.nec.2010.03.011 pmid:20561492

    CrossRefPubMed
15. 15.↵
    1. Lai LM,
    2. Sato TS,
    3. Kandemirli SG, et al

    . Neuroimaging of neonatal stroke: venous focus. Radiographics 2024;44:e230117 doi:10.1148/rg.230117 pmid:38206831

    CrossRefPubMed
16. 16.↵
    1. Hu J,
    2. Yu Y,
    3. Juhasz C, et al

    . MR susceptibility weighted imaging (SWI) complements conventional contrast enhanced T1 weighted MRI in characterizing brain abnormalities of Sturge-Weber syndrome. J Magn Reson Imaging 2008;28:300–07 doi:10.1002/jmri.21435 pmid:18666142

    CrossRefPubMed
17. 17.↵
    1. Parsa CF

    . Sturge-Weber syndrome: a unified pathophysiologic mechanism. Curr Treat Options Neurol 2008;10:47–54 doi:10.1007/s11940-008-0006-0 pmid:18325299

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Pedregosa F,
    2. Varoquaux G,
    3. Gramfort A, et al

    . Scikit-learn: machine learning in Python. J Mach Learn Res 2011;12:2525–30
19. 19.↵
    1. Mentzel H-J,
    2. Dieckmann A,
    3. Fitzek C, et al

    . Early diagnosis of cerebral involvement in Sturge-Weber syndrome using high-resolution BOLD MR venography. Pediatr Radiology 2005;35:85–90 doi:10.1007/s00247-004-1333-2 pmid:15480615

    CrossRefPubMed
20. 20.↵
    1. Moritani T,
    2. Kim J,
    3. Sato Y, et al

    . Abnormal hypermyelination in a neonate with Sturge-Weber syndrome demonstrated on diffusion-tensor imaging. J Magn Reson Imaging 2008;27:617–20 doi:10.1002/jmri.21248 pmid:18224675

    CrossRefPubMed
21. 21.↵
    1. Curé JK,
    2. Holden KR,
    3. Van Tassel P

    . Progressive venous occlusion in a neonate with Sturge-Weber syndrome: demonstration with MR venography. AJNR Am J Neuroradiol 1995;16:1539–42 pmid:7484651

    PubMedWeb of Science
22. 22.↵
    1. Mandelstam S,
    2. Andronikou S

    . MRI evaluation of venous abnormalities in children with Sturge-Weber syndrome. J Pediatr Neurol 2015;02:29–32 doi:10.1055/s-0035-1557187

    CrossRef
23. 23.↵
    1. Raets M,
    2. Dudink J,
    3. Raybaud C, et al

    . Brain vein disorders in newborn infants. Dev Med Child Neurol 2015;57:229–40 doi:10.1111/dmcn.12579 pmid:25212961

    CrossRefPubMed
24. 24.↵
    1. Cagneaux M,
    2. Paoli V,
    3. Blanchard G, et al

    . Pre- and postnatal imaging of early cerebral damage in Sturge-Weber syndrome. Pediatr Radiology 2013;43:1536–39 doi:10.1007/s00247-013-2743-9 pmid:23877502

    CrossRefPubMed
25. 25.↵
    1. Catsman-Berrevoets CE,
    2. Koudijs SM,
    3. Buijze MSJ, et al

    . Early MRI diagnosis of Sturge Weber Syndrome type 1 in infants. Eur J Paediatr Neurol 2022;38:66–72 doi:10.1016/j.ejpn.2022.04.002 pmid:35461064

    CrossRefPubMed
26. 26.↵
    1. Wetzel-Strong SE,
    2. Galeffi F,
    3. Benavides C, et al

    . Developmental expression of the Sturge-Weber syndrome-associated genetic mutation in Gnaq: a formal test of Happle’s paradominant inheritance hypothesis. Genetics 2023;224:iyad077 doi:10.1093/genetics/iyad077

    CrossRefPubMed
27. 27.↵
    1. Roach ES

    . Neurocutaneous syndromes. Pediatr Clin North Am 1992;39:591–620 doi:10.1016/s0031-3955(16)38367-5 pmid:1635798

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Dutkiewicz A-S,
    2. Ezzedine K,
    3. Mazereeuw-Hautier J, et al

    ; Groupe de Recherche Clinique en Dermatologie Pédiatrique. A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain. J Am Acad Dermatol 2015;72:473–80 doi:10.1016/j.jaad.2014.11.009 pmid:25592619

    CrossRefPubMed
29. 29.↵
    1. Waelchli R,
    2. Aylett SE,
    3. Robinson K, et al

    . New vascular classification of port-wine stains: improving prediction of Sturge-Weber risk. Br J Dermatol 2014;171:861–67 doi:10.1111/bjd.13203 pmid:24976116

    CrossRefPubMed
30. 30.↵
    1. Mehta M,
    2. Salas AH,
    3. Fay A

    . Trigeminal dermatome distribution in patients with glaucoma and facial port wine stain. Dermatology 2009;219:219–24 doi:10.1159/000235546 pmid:19672053

    CrossRefPubMed
31. 31.↵
    1. Sánchez-Espino LF,
    2. Ivars M,
    3. Antoñanzas J, et al

    . Sturge-Weber syndrome: a review of pathophysiology, genetics, clinical features, and current management approache. Appl Clin Genet 2023;16:63–81 doi:10.2147/TACG.S363685 pmid:37124240

    CrossRefPubMed
32. 32.↵
    1. Mankel FL,
    2. Papandreou A,
    3. Mankad K, et al

    . Diagnostic pathway and management of first seizures in infants with Sturge-Weber syndrome. Dev Med Child Neurol 2024 Jun 12. Epub ahead of print. doi:10.1111/dmcn.15983

    CrossRef
33. 33.↵
    1. Madhukar M,
    2. Choudhary AK,
    3. Boal DK, et al

    . Choroid plexus: normal size criteria on neuroimaging. Surg Radiology Anat 2012;34:887–95 doi:10.1007/s00276-012-0980-5 pmid:22618012

    CrossRefPubMed
34. 34.↵
    1. Venkatakrishna SSB,
    2. Viaene AN,
    3. Cerron-Vela CR, et al

    . Radio-pathologic correlation: no pial angioma-subarachnoid varicose network drainage pathway in Sturge-Weber syndrome. Childs Nerv Syst 2024;40:2929–34 doi:10.1007/s00381-024-06490-w pmid:38864886

    CrossRefPubMed
35. 35.↵
    1. Bergsland N,
    2. Ramasamy D,
    3. Tavazzi E, et al

    . Leptomeningeal contrast enhancement is related to focal cortical thinning in relapsing-remitting multiple sclerosis: a cross-sectional MRI study. AJNR Am J Neuroradiol 2019;40:620–25 doi:10.3174/ajnr.A6011 pmid:30872420

    Abstract/FREE Full Text
36. 36.↵
    1. Day AM,
    2. Hammill AM,
    3. Juhász C, et al

    ; National Institutes of Health Sponsor: Rare Diseases Clinical Research Network (RDCRN) Brain and Vascular Malformation Consortium (BVMC) SWS Investigator Group. Hypothesis: presymptomatic treatment of Sturge-Weber syndrome with aspirin and antiepileptic drugs may delay seizure onset. Pediatr Neurol 2019;90:8–12 doi:10.1016/j.pediatrneurol.2018.04.009 pmid:30482419

    CrossRefPubMed
37. 37.↵
    1. Sabeti S,
    2. Ball KL,
    3. Bhattacharya SK, et al

    . Consensus statement for the management and treatment of Sturge-Weber Syndrome: neurology, neuroimaging, and ophthalmology recommendations. Pediatr Neurol 2021;121:59–66 doi:10.1016/j.pediatrneurol.2021.04.013 pmid:34153815

    CrossRefPubMed
38. 38.↵
    1. Nguyen V,
    2. Hochman M,
    3. Mihm MC, et al

    . The pathogenesis of port wine stain and Sturge Weber Syndrome: complex interactions between genetic alterations and aberrant MAPK and PI3K activation. Int J Mol Sci 2019;20:2243 doi:10.3390/ijms20092243

    CrossRefPubMed
39. 39.↵
    1. Huang L,
    2. Bichsel C,
    3. Norris AL, et al

    . Endothelial GNAQ p.R183Q increases ANGPT2 (Angiopoietin-2) and drives formation of enlarged blood vessels. Arterioscler Thromb Vasc Biol 2022;42:e27–43 doi:10.1161/ATVBAHA.121.316651 pmid:34670408

    CrossRefPubMed
40. 40.↵
    1. Zhu H

    . Constructing an enterprise management system using an improved clustering algorithm. Mobile Information Systems 2022;2022:1–9 doi:10.1155/2022/9119452

    CrossRef